lactobacillus crispatus Lc262-1
Phase 3- Indications
- Bacterial vaginosis
Company intelligence / Profile preview
欧赛微科生物
Suzhou, Jiangsu Province, Chinabusinesswire.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
The company’s lead product, a vaginal Lactobacillus crispatus live biotherapeutic capsule developed from a proprietary strain Lc262‑1 isolated from healthy Chinese women, has completed a multicenter randomized double-blind placebo-controlled Phase III clinical trial in bacterial vaginosis. The study met both primary and secondary endpoints and demonstrated significant reduction in recurrence of gynecological infections. The company’s platform supports further development of microecological drugs for gynecological health.
- Therapeutic areas
- Infectious DiseasesWomen's Health
- Modalities
- Live biotherapeutic product therapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Not specifically disclosed; investors include Summit Fund and Diamondhide Fund.
Beyond the preview
Go deeper on 欧赛微科生物.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 欧赛微科生物.